Comparison of idrabiotaparinux with vitamin K antagonists for prevention of thromboembolism in patients with atrial fibrillation: the Borealis‐AF study

ConclusionIf anything, despite its early termination the idrabiotaparinux regimen studied suggested a comparable efficacy to dose‐adjusted warfarin, with a lower bleeding risk.This article is protected by copyright. All rights reserved.

Source: Journal of Thrombosis and Haemostasis - March 5, 2014 Category: Hematology Authors: H.R. Buller, J. Halperin, G.J. Hankey, G. Pillion, M.H. Prins, G.E. Raskob Tags: Original Article ‐ Clinical Haemostasis and Thrombosis Source Type: research